Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A rat model of the 131I-induced changes in thyroid function.

C P Reilly, R G Symons, M L Wellby

    Journal of Endocrinological Investigation
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Longitudinal outcomes after endovascular repair of abdominal aortic aneurysms.

    Vascular and endovascular surgery·2008
    Same author

    Serum interleukin-6 and thyroid hormones in rheumatoid arthritis.

    Metabolism: clinical and experimental·2001
    Same author

    Influence of imipramine on the hypothalamic/pituitary/thyroid axis of the rat.

    Metabolism: clinical and experimental·1998
    Same author

    Effect of high room temperature on urinary iodine assay.

    Clinical chemistry·1997
    Same author

    Effect of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 on the control of thyrotropin secretion.

    Life sciences·1995
    Same author

    The effect of oleic acid on the secretion of thyrotrophin and growth hormone by cultured rat anterior pituitary cells.

    The Journal of endocrinology·1994

    This study models the effects of Iodine-131 (131I) treatment in thyrotoxic patients. Iodine-131 effectively reduces thyroxine (T4) and increases thyrotropin (TSH) in rats, mimicking human patient outcomes.

    Area of Science:

    • Endocrinology
    • Nuclear Medicine
    • Pharmacology

    Background:

    • Thyrotoxic patients treated with Iodine-131 (131I) often exhibit low thyroxine (T4), normal triiodothyronine (T3), and elevated thyrotropin (TSH) serum levels.
    • A reliable animal model is needed to study this specific endocrine state.

    Purpose of the Study:

    • To develop and validate a rat model that replicates the low T4, raised TSH condition observed in human patients post-131I therapy.
    • To investigate the dose-dependent effects of 131I on thyroid hormone levels and TSH in rats.

    Main Methods:

    • Rats were administered varying doses of Iodine-131 (50, 150, or 450 mu Ci).
    • Serum concentrations of T4, T3, and TSH were measured.
    • Thyroid function was assessed by analyzing these serum parameters.

    Related Experiment Videos

  • The clearance rate of 131I from the rats was determined.

    • Main Results:

    • A dose of 50 mu Ci 131I had no significant impact on thyroid function.
    • Doses of 150 mu Ci and 450 mu Ci 131I significantly decreased serum T4 and significantly increased serum TSH.
    • Serum T3 concentrations remained unchanged across all experimental groups compared to controls.
    • 131I clearance followed a single exponential curve with a half-life of 3.38 +/- 0.61 days.
    • Body weight did not influence the T4 level changes induced by 131I.

    Conclusions:

    • The study successfully established a rat model for the low T4, raised TSH state seen in thyrotoxic patients after 131I treatment.
    • The model demonstrates that specific doses of 131I can induce hypothyroidism-like changes (low T4, high TSH) without affecting T3 levels.
    • This validated rat model is suitable for further research into the mechanisms and management of thyroid dysfunction following radioiodine therapy.